Oxacillin-induced tissue necrosis

Annals of Pharmacotherapy

Volumn 33, Issue 10, 1999, Pages 1060-1062

  Fromm, Laurie A ^a   Graham, Diane L ^a  

^a SAINT VINCENT HOSPITAL   (United States)

Author keywords

Extravasation; Oxacillin; Tissue necrosis

Indexed keywords

FUROSEMIDE; GLIPIZIDE; HEPARIN; METFORMIN; OXACILLIN; POTASSIUM CHANNEL AFFECTING AGENT; SOTALOL; TAMOXIFEN;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; CONCENTRATION RESPONSE; EXTRAVASATION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; PACEMAKER; PRIORITY JOURNAL; RISK FACTOR; TISSUE NECROSIS;

AGED; ANTIBIOTIC PROPHYLAXIS; ERYTHEMA; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; NECROSIS; OXACILLIN; PENICILLINS;

EID: 0032834909     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18387     Document Type: Article

References (21)

1. Zenk KE, Dungy CI, Greene GR. Nafcillin extravasation injury. Use of hyaluronidase as an antidote. Am J Dis Child 1981;135:113-4.
2. Upton J, Mulliken JB, Murray JE. Major intravenous extravasation injuries. Am J Surg 1979;137:497-506.
3. Brown AS, Hoelzer DJ, Piercy SA. Skin necrosis from extravasation of intravenous fluids in children. Plast Reconstr Surg 1979;64:145-50.
4. Robinson DC, Cookson TL, Grisafe JA. Concentration guidelines for parenteral antibiotics in fluid-restricted patients. Drug Intell Clin Pharm 1987;21:985-9.
5. AHFS drug information 99. McEvoy GK, ed. Oxacillin sodium. Bethesda, MD: American Society of Health-System Pharmacists, 1999:353-6.
6. Trissel LA. Handbook on injectable drugs. 9th ed. Bethesda, MD: American Society of Health-System Pharmacists 1996:826-30.
7. Package insert. Oxacillin (oxacillin sodium for injection USP). Princeton, NJ: Apothecon, 1990.
8. MacCara ME. Extravasation: a hazard of intravenous therapy. Drug Intell Clin Pharm 1983;17:713-7.
9. Tilden SJ, Craft JC, Cano R, Daum RS. Cutaneous necrosis associated with intravenous nafcillin therapy. Am J Dis Child 1980;134:1046-8.
10. Dahlgren AF. Adverse drug reactions in home care patients receiving nafcillin or oxacillin. Am J Health Syst Pharm 1997;54:1176-9.
11. Burd DAR, Santis G, Milward TM. Severe extravasation injury: an avoidable iatrogenic disaster. Br Med J 1985;290:1579-80.
12. Halpern MT, Yabroff KR, Sloan EP. Costs of medical resource use associated with complication of IV drug therapy. Formulary 1997;32:944-59.
13. Hardy SB, Hamilton JM. Treatment of tissue necrosis following intravenous use of norepinephrine. Plast Reconstr Surg 1957;20:360.
14. Chen JL, O'Shea M. Extravasation injury associated with low-dose dopamine. Ann Pharmacother 1998;32:545-8.
15. Zenk KE. Management of intravenous extravasations. Infusion 1981;5: 77-9.
16. Jameson J, O'Donnell J. Guidelines for extravasation of intravenous drugs. Infusion 1983;7:157-65.
17. Gil M-E, Mateu J. Treatment of extravasation from parenteral nutrition solution. Ann Pharmacother 1998;32:51-5.
18. Bertelli G, Dini D, Forno GB, Gozza A, Silvestro S, Venturini M, et al. Hyaluronidase as an antidote to extravasation of vinca alkaloids: clinical results. J Cancer Res Clin Oncol 1994;120:505-6.
19. Comas D, Mateu J. Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion. Ann Pharmacother 1996; 30:244-6.
20. Mateu J, Alzamora M, Franco M, Busan MJ. Ifosfamide extravasation. Ann Pharmacother 1994;28:1243-4.
21. Pettit J, Hughes K. Intravenous extravasation: mechanisms, management, and prevention. J Perinat Neonatal Nurs 1993;6:69-79.